VJHemOnc is committed to improving our service to you

SOHO 2020 | Significance of p53 mutations in AML

VJHemOnc is committed to improving our service to you

David Sallman

David Sallman, MD, H. Lee Moffitt Cancer Center, Tampa, FL, outlines the significance of mutant p53 in acute myeloid leukemia (AML), and the clinical characteristics associated with this mutational profile, including 10-30% blast state, cytogenetic complexity, and severe pancytopenia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter